Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

26th Jun 2006 18:09

United Drug PLC26 June 2006 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons Notes: This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990. (1) An issuer making a notification in respect of a transaction relatingto the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating tothe shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to adirector/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24 (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug Plc (i)a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) and (ii) - (iii) 3 Name of person discharging managerial 4 State whether notification realties to a person connected with a person responsibilities/director discharging managerial responsibilities/director named in 3 and identify the connected person Ms. Claire Heeley N/A5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above7 Name or registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/A9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares acquired N/A N/A11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares disposed N/A N/A13 Price per share or value of 14 Date and place of transaction transaction 23rd June 2006 N/A15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury N/A shares should not be taken into account when calculating percentage) N/A If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 23rd June 2006 15,000 From 23 June 2009 to 22 June 2016 20,000 From 23 June 2011 to 22 June 201619 Total amount paid (if any) for grant of the option 20 Description of shares or debentures involved (class and number) N/A Ordinary shares of €0.05 each21 Exercise price (if fixed at time of grant) or indication that 22 Total number of shares or debentures over which the price is to be fixed at the time of exercise options are held following notification €3.32 120,000 €0.05 Ordinary Shares23 Any additional information 24 Name of contact and telephone number for queries N/A Claire Heeley (01-4637721) Name and signature of authorised officer of issuer responsible for making notification __________________Claire Heeley_______________________ Date of notification _______26th June 2006___________________ SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons Notes: This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990. (1) An issuer making a notification in respect of a transaction relating tothe shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating tothe shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to adirector/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24 (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug Plc (i)a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) and (ii) - (iii) 3 Name of person discharging managerial 4 State whether notification realties to a person connected with a person responsibilities/director discharging managerial responsibilities/director named in 3 and identify the connected person Mr. Liam Fitzgerald N/A5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above7 Name or registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of Stock Options N/A9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares acquired N/A N/A11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares disposed N/A N/A13 Price per share or value of 14 Date and place of transaction transaction 23rd June 2006 N/A15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury N/A shares should not be taken into account when calculating percentage) N/A If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 23rd June 2006 90,000 from 23 June 2009 to 22 June 2016 90,000 from 23 June 2011 to 22 June 201619 Total amount paid (if any) for grant of the option 20 Description of shares or debentures involved (class and number) N/A Ordinary shares of €0.05 each21 Exercise price (if fixed at time of grant) or indication that 22 Total number of shares or debentures over which the price is to be fixed at the time of exercise options are held following notification €3.32 1,233,000 €0.05 Ordinary Shares23 Any additional information 24 Name of contact and telephone number for queries N/A Claire Heeley (01-4637721) Name and signature of authorised officer of issuer responsible for making notification ___________________Claire Heeley _____________________ Date of notification ____26th June 2006______________________ SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons Notes: This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990. (1) An issuer making a notification in respect of a transaction relating tothe shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating tothe shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to adirector/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24 (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug Plc (i)a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) and (ii) - (iii) 3 Name of person discharging managerial 4 State whether notification realties to a person connected with a person responsibilities/director discharging managerial responsibilities/director named in 3 and identify the connected person Mr. Barry McGrane N/A5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above7 Name or registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/A9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares acquired N/A N/A11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares disposed N/A N/A13 Price per share or value of 14 Date and place of transaction transaction 23rd June 2006 N/A15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury N/A shares should not be taken into account when calculating percentage) N/A If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 23rd June 2006 45,000 from 23 June 2009 to 22 June 2016 50,000 from 23 June 2011 to 22 June 201619 Total amount paid (if any) for grant of the option 20 Description of shares or debentures involved (class and number) N/A Ordinary shares of €0.05 each21 Exercise price (if fixed at time of grant) or indication that 22 Total number of shares or debentures over which the price is to be fixed at the time of exercise options are held following notification €3.32 728,500 €0.0523 Any additional information 24 Name of contact and telephone number for queries N/A Claire Heeley (01-4637721) Name and signature of authorised officer of issuer responsible for making notification ____________________Claire Heeley_____________________ Date of notification ______26th June 2006_____________________________ SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons Notes: This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990. (1) An issuer making a notification in respect of a transaction relating tothe shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating tothe shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to adirector/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24 (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug Plc (i)a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) and (ii) - (iii)3 Name of person discharging managerial 4 State whether notification realties to a person connected with a person responsibilities/director discharging managerial responsibilities/director named in 3 and identify the connected person Ms Annette Flynn N/A5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above7 Name or registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/A9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares acquired N/A N/A11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares disposed N/A N/A13 Price per share or value of 14 Date and place of transaction transaction 23rd June 2006 N/A15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury N/A shares should not be taken into account when calculating percentage) N/A If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 23rd June 2006 45,000 from 23 June 2009 to 22 June 2016 40,000 from 23 June 2011 to 22 June 201619 Total amount paid (if any) for grant of the option 20 Description of shares or debentures involved (class and number) N/A Ordinary shares of €0.05 each21 Exercise price (if fixed at time of grant) or indication that 22 Total number of shares or debentures over which the price is to be fixed at the time of exercise options are held following notification €3.32 451,000 €0.05 Ordinary shares23 Any additional information 24 Name of contact and telephone number for queries N/A Claire Heeley (01-4637721) Name and signature of authorised officer of issuer responsible for making notification ___________________Claire Heeley______________________ Date of notification ____26th June 2006_______________________ SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons Notes: This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990. (1) An issuer making a notification in respect of a transaction relating tothe shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating tothe shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to adirector/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24 (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug Plc (i)a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) and (ii) - (iii)3 Name of person discharging managerial 4 State whether notification realties to a person connected with a person responsibilities/director discharging managerial responsibilities/director named in 3 and identify the connected person Mr. Chris Corbin N/A5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary shares of €0.05 each. As per 3 above7 Name or registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/A9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares acquired N/A N/A11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares disposed N/A N/A13 Price per share or value of 14 Date and place of transaction transaction 23rd June 2006 N/A15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury N/A shares should not be taken into account when calculating percentage) N/A If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 23rd June 2006 45,000 from 23 June 2009 to 22 June 2016 40,000 from 23 June 2011 to 22 June 201619 Total amount paid (if any) for grant of the option 20 Description of shares or debentures involved (class and number) N/A Ordinary shares of €0.05 each21 Exercise price (if fixed at time of grant) or indication that 22 Total number of shares or debentures over which the price is to be fixed at the time of exercise options are held following notification €3.32 566,000 €0.05 Ordinary shares23 Any additional information 24 Name of contact and telephone number for queries N/A Claire Heeley (01-4637721) Name and signature of authorised officer of issuer responsible for making notification ____________________Claire Heeley______________________ Date of notification _______26th June 2006____________________________ This announcement has been issued through the Companies Announcement Service of the Irish Stock Exchange This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00